These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2198281)
41. Dihydropyrimidine dehydrogenase in livers from mouse and rat, and in human liver, colon tumors, and mucosa in relation to anabolism of 5-fluorouracil. Peters GJ; van Groeningen CJ; Pinedo HM Adv Exp Med Biol; 1998; 431():633-6. PubMed ID: 9598142 [No Abstract] [Full Text] [Related]
43. Equilibrium substrate binding studies of the malic enzyme of pigeon liver. Equivalence of nucleotide sites and anticooperativity associated with the binding of L-malate to the enzyme-manganese(II)-reduced nicotinamide adenine dinucleotide phosphate ternary complex. Pry TA; Hsu RY Biochemistry; 1980 Mar; 19(5):951-62. PubMed ID: 7356971 [TBL] [Abstract][Full Text] [Related]
44. Transient-State Analysis of Porcine Dihydropyrimidine Dehydrogenase Reveals Reductive Activation by NADPH. Beaupre BA; Forouzesh DC; Moran GR Biochemistry; 2020 Jul; 59(26):2419-2431. PubMed ID: 32516529 [TBL] [Abstract][Full Text] [Related]
50. The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. Askonas LJ; Ricigliano JW; Penning TM Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):835-41. PubMed ID: 1898369 [TBL] [Abstract][Full Text] [Related]
51. Trihydroxynaphthalene reductase from Magnaporthe grisea: realization of an active center inhibitor and elucidation of the kinetic mechanism. Thompson JE; Basarab GS; Andersson A; Lindqvist Y; Jordan DB Biochemistry; 1997 Feb; 36(7):1852-60. PubMed ID: 9048570 [TBL] [Abstract][Full Text] [Related]
52. Pyrimidine catabolism: individual characterization of the three sequential enzymes with a new assay. Traut TW; Loechel S Biochemistry; 1984 May; 23(11):2533-9. PubMed ID: 6433973 [TBL] [Abstract][Full Text] [Related]
53. Pyrimidine reducing enzymes of rat liver. Hallock RO; Yamada EW Can J Biochem; 1976 Feb; 54(2):178-84. PubMed ID: 1260500 [TBL] [Abstract][Full Text] [Related]
55. Correlation between catalytic activity and protein content for the polymorphically expressed dihydropyrimidine dehydrogenase in human lymphocytes. Fernandez-Salguero P; Gonzalez FJ; Etienne MC; Milano G; Kimura S Biochem Pharmacol; 1995 Sep; 50(7):1015-20. PubMed ID: 7575656 [TBL] [Abstract][Full Text] [Related]
56. Role of dihydropyrimidine dehydrogenase in the uridine nucleotide metabolism in the rat liver. Fujimoto S; Kikugawa M; Kaneko M; Tamaki N J Nutr Sci Vitaminol (Tokyo); 1992 Feb; 38(1):39-48. PubMed ID: 1629785 [TBL] [Abstract][Full Text] [Related]
57. Energy-transducing nicotinamide nucleotide transhydrogenase. Nucleotide binding properties of the purified enzyme and proteolytic fragments. Yamaguchi M; Hatefi Y J Biol Chem; 1993 Aug; 268(24):17871-7. PubMed ID: 8102370 [TBL] [Abstract][Full Text] [Related]
58. Development and characterization of a monoclonal antibody with cross-reactivity towards uracil and thymine, and its potential use in screening patients treated with 5-fluorouracil for possible risks. Honda T; Inagawa H; Fukushima M; Moriyama A; Soma G Clin Chim Acta; 2002 Aug; 322(1-2):59-66. PubMed ID: 12104082 [TBL] [Abstract][Full Text] [Related]